The effects of sevoflurane on the QT interval in patients with diabetes

The effects of sevoflurane on the QT interval in patients with diabetes - The effects of sevoflurane on the QT interval in patients with diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020680

Enrollment

Registered

2016-01-21

Start date

2014-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: general anesthetic patient

Exclusion criteria

Exclusion criteria: Heart surgery Pregnant woman Atrial fibrillation Bundle branch block

Design outcomes

Primary

Measure	Time frame
ECG QTc interval Sevoflurane administration before and After administration, 5 minutes, 10 minutes, 30 minutes, 60 minutes, 90 minutes, 120 minutes	—

Secondary

Measure	Time frame
ECG Tp-e interval Sevoflurane administration before and After administration, 5 minutes, 10 minutes, 30 minutes, 60 minutes, 90 minutes, 120 minutes	—

Countries

Japan

Contacts

Public ContactSeishi Kimura

Kindai University Faculty of Medicine Department of Anesthesiology

s-kimura@med.kindai.ac.jp072-366-0221

Outcome results